-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 TlHN7ELJJ2Pz6p+60DPixpFEx4GCFj+1PVqzcC/T4GNejzlv0jHGJFaQZ1F4wLaN
 DLzI9DxIR+RFtBBoTpYRDw==

<SEC-DOCUMENT>0000915656-99-000007.txt : 19990217
<SEC-HEADER>0000915656-99-000007.hdr.sgml : 19990217
ACCESSION NUMBER:		0000915656-99-000007
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19990216

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H&Q HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		STANDARD INDUSTRIAL CLASSIFICATION:	UNKNOWN SIC - 0000 [0000]
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		
		SEC FILE NUMBER:	005-40606
		FILM NUMBER:		99540341

	BUSINESS ADDRESS:	
		STREET 1:		50 ROWES WHARF
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6175740537

	MAIL ADDRESS:	
		STREET 1:		50 ROWES WHARF
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			YALE UNIVERSITY
		CENTRAL INDEX KEY:			0000938582
		STANDARD INDUSTRIAL CLASSIFICATION:	 []
		IRS NUMBER:				06646973
		STATE OF INCORPORATION:			CT
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		230 PROSPECT STREET
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511-2107
		BUSINESS PHONE:		2034325761

	MAIL ADDRESS:	
		STREET 1:		YALE UNIVERSITY INVESTMENT OFFICE
		STREET 2:		230 PROSPECT STREET
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511-2107
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<TEXT>


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Amendment No. 3

H&Q HEALTHCARE INVESTORS
(Name of Issuer)

Common Stock, par value $0.01 per share
(Title of Class of Securities)

_404052-10-2_
 (CUSIP Number)

Check the appropriate box to designate the rule purusant to which this Schedule
is filed:
[X]  Rule 13d-1(b)
                                                       
1)   Name and I.R.S. Identification No. of Reporting Person:

     Yale University
     I.R.S. Number 06-0646973-N
                                                       
2)   Check the Appropriate Box if a Member of a Group:

     (a)  (Not Applicable)
     (b)  (Not Applicable)
                                                       
3)   SEC Use Only
                                                       
4)   Citizenship or Place of Organization:

     Yale University is a Connecticut corporation.

Number of Shares         (5)  Sole Voting Power  -  1,371,759
Beneficially Owned by                                       
Each Reporting           (6)  Shared Voting Power (Not Applicable)
Person With:                                                
                    (7)  Sole Dispositive Power  -  1,371,759
                                                       
                    (8)  Shared Dispositive Power (Not Applicable)
                                                       
9)   Aggregate Amount Beneficially Owned by Each Reporting Person: 1,371,759
                                                       
10)  Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
     (Not  Applicable)
                                                       
11)  Percent of Class Represented by Amount in Row (9):  14.5%
                                                       
12)  Type of Reporting Person:  EP
                                                       
Item 1.   Issuer:

     (a)  Name of Issuer:
     
          H&Q Healthcare Investors (the "Company")

     (b)  Address of Issuer's Principal Executive Office:

          H&Q Capital Management Incorporated
          50 Rowes Wharf - 4th Floor
          Boston, MA 02110-3328

Item 2.   Person Filing:

     (a)  Name of Person Filing:

          Yale University

     (b)  Address of Principal Office:
          
          Yale University
          Investments Office
          230 Prospect Street
          New Haven, CT 06511-2107

     (c)  Citizenship:

          Yale University is a Connecticut corporation.

     (d)  Title of Class of Securities:

          Common Stock

     (e)  CUSIP Number:

          404052-10-2

Item 3.   Status of Person Filing:

If this statement is filed pursuant to rules 13d-1(b) or 13d-2(b), check whether
the person filing is a:

 . . . . 

(f)  [X]  . . . Endowment Fund; see section 240.13d-1(b)(1)(ii)(F).

 . . . . 

Item 4.   Ownership:

     (a)  Amount Beneficially Owned:           1,371,759

     (b)  Percent of Class:   14.5%

     (c)  Number of Shares as to which such person has:

          (i)  sole power to vote or to direct the vote:    
               1,371,759

          (ii) shared power to vote or to direct the vote:
               (Not  Applicable)

          (iii)     sole power to dispose or to direct the disposition of:
               1,371,759

          (iv) shared power to dispose or to direct the disposition of:
               (Not Applicable)

Item 5.   Ownership of Five Percent or Less of a Class:

          (Not Applicable)

Item 6.   Ownership of More than Five Percent on Behalf of Another Person:

          (Not Applicable)

Item 7.   Identification and Classification of the Subsidiary Which Acquired    
     the Security Being Reported on By the Parent Holding Company:

          (Not Applicable)

Item 8.   Identification and Classification of Members of Group:

          (Not Applicable)

Item 9.   Notice of Dissolution of Group:

          (Not Applicable)

Item 10.  Certification:

     By signing below I certify that, to the best of my knowledge and belief, 
the securities referred to above were acquired in the ordinary course of 
business and were not acquired for the purpose of and do not have the effect 
of changing or influencing the control of the issuer of such securities and 
were not acquired in connection with or as a participant in any transaction 
having such purpose or effect.

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I 
certify that the information set forth in this statement is true, complete and 
correct.


Date:  February 16, 1999

                         /s/ David F. Swensen     
                         Name:     David F. Swensen
                         Title:    Chief Investment Officer

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
